Latest Period
Q2 2026
Security Snapshot
ALUMIS INC. - COMMON STOCK (ALMS) Institutional Ownership
CUSIP: 022307102
13F Institutional Holders and Ownership History from Q2 2024 to Q2 2026
Institutions Reporting
198
Shares (Excl. Options)
118,116,574
Price
$28.14
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- ALMS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 118,116,574
- Total 13F value
- $3,322,016,609
- Portfolio coverage rank
- 0.01%
- Share change
- +3,294,527
- Value change
- +$104,109,206
- Number of holders
- 198
- Shares outstanding
- 123,075,818
- SEC-reported price per share
- $27.53
- Insider filing price
- $27.53
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ALMS - ALUMIS INC. - COMMON STOCK is tracked under CUSIP 022307102.
- 198 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 193 to 198 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,520,822,473 to $3,322,016,609.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 198 institutions filings for Q2 2026.
Security key
022307102
Latest holder period
Q2 2026
13F holders
198
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
ALMS full holder history
ALUMIS INC. SEC filings
ALUMIS INC. company facts
ALUMIS INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 022307102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
ALMS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Foresite Capital Fund VI LP | 13% | -10% | $422,163,758 | -$13,341,970 | 15,693,820 | -3.1% | James B. Tananbaum | 01 Apr 2026 |
| AyurMaya Capital Management Company, LP | 12% | -22% | $303,702,522 | 15,139,707 | 0% | AyurMaya Capital Management Company, LP | 14 May 2026 | |
| Deep Track Capital, LP | 6% | $162,185,631 | 7,362,035 | Deep Track Capital, LP | 30 Mar 2026 | |||
| BlackRock, Inc. | 5.7% | $198,935,786 | 7,069,502 | BlackRock, Inc. | 30 Jun 2026 | |||
| FMR LLC | 5.5% | $190,213,677 | 6,769,170 | FMR LLC | 30 Jun 2026 | |||
| Samsara BioCapital, L.P. | 5.4% | +2% | $61,929,972 | +$11,811,946 | 6,345,219 | +24% | Srinivas Akkaraju | 09 Jan 2026 |
| venBio Global Strategic Fund IV, L.P. | 4.8% | $21,297,292 | 4,619,803 | venBio Global Strategic Fund IV, L.P. | 30 Jun 2025 |
As of 30 Jun 2026, 198 institutional investors reported holding 118,116,574 shares of ALUMIS INC. - COMMON STOCK (ALMS). This represents 96% of the company’s total 123,075,818 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
79%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | 12% | 15,139,707 | 0% | 100% | $426,031,355 |
| BlackRock, Inc. | 6.7% | 8,218,151 | +15% | 0% | $231,258,771 |
| FMR LLC | 5.5% | 6,769,170 | +595% | 0.01% | $190,484,444 |
| Deep Track Capital, LP | 5.2% | 6,348,558 | -6.3% | 2.6% | $178,648,422 |
| SAMSARA BIOCAPITAL, LLC | 5.2% | 6,345,219 | 0% | 15% | $178,554,463 |
| Foresite Capital Management V, LLC | 4.8% | 5,896,995 | 0% | 46% | $165,941,439 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.2% | 5,199,838 | +58% | 0.01% | $146,325,000 |
| venBio Partners LLC | 3.7% | 4,528,408 | 0% | 25% | $127,429,401 |
| Foresite Capital Management VI LLC | 3.5% | 4,247,670 | 0% | 19% | $119,529,434 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 4,215,703 | +4.5% | 0% | $118,629,882 |
| Nextech Invest Ltd. | 2.9% | 3,540,998 | 0% | 4.8% | $99,643,684 |
| Cormorant Asset Management, LP | 2.7% | 3,285,596 | -17% | 4.8% | $92,456,671 |
| Saturn V Capital Management LP | 2.4% | 2,915,443 | -9% | 12% | $82,040,566 |
| Octagon Capital Advisors LP | 2.3% | 2,830,700 | 0% | 7.3% | $79,655,898 |
| Jupiter Topco LLC | 1.9% | 2,355,122 | 0% | 0.03% | $66,237,806 |
| STATE STREET CORP | 1.8% | 2,187,266 | +21% | 0% | $61,549,665 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 2,168,517 | +13% | 0% | $61,033,791 |
| MPM BIOIMPACT LLC | 1.6% | 2,019,020 | -15% | 3.5% | $56,815,223 |
| BAKER BROS. ADVISORS LP | 1.6% | 2,012,500 | 0% | 0.28% | $56,631,750 |
| SR One Capital Management, LP | 1.6% | 1,959,896 | 0% | 5.3% | $55,151,473 |
| Invesco Ltd. | 0.95% | 1,173,518 | -22% | 0% | $33,022,796 |
| NOVO HOLDINGS A/S | 0.89% | 1,100,000 | 1.8% | $30,954,000 | |
| PRINCIPAL FINANCIAL GROUP INC | 0.87% | 1,068,060 | +0.95% | 0.01% | $30,055,208 |
| JPMORGAN CHASE & CO | 0.79% | 969,617 | +13% | 0% | $26,407,356 |
| D. E. Shaw & Co., Inc. | 0.79% | 968,234 | +69% | 0.02% | $27,246,105 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 118,116,574 | $3,322,016,609 | +$104,109,206 | $28.14 | 198 |
| 2026 Q1 | 114,507,712 | $2,520,822,473 | +$771,555,180 | $22.03 | 193 |
| 2025 Q4 | 78,901,192 | $770,079,479 | +$72,305,373 | $9.76 | 132 |
| 2025 Q3 | 77,994,182 | $311,197,950 | -$66,383 | $3.99 | 129 |
| 2025 Q2 | 78,328,492 | $234,986,451 | +$114,158,793 | $3.00 | 112 |
| 2025 Q1 | 40,203,252 | $246,848,226 | -$2,907,402 | $6.14 | 72 |
| 2024 Q4 | 40,261,542 | $316,456,858 | +$6,196,390 | $7.86 | 64 |
| 2024 Q3 | 35,212,710 | $376,073,647 | +$60,319,979 | $10.68 | 52 |
| 2024 Q2 | 28,575,030 | $380,047,605 | +$380,047,605 | $13.30 | 29 |